The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10872 malaria professionals are enjoying the free benefits of MalariaWorld today

perillyl alcohol

NOT Open Access | Perillyl alcohol reduces parasite sequestration and cerebrovascular dysfunction during experimental cerebral malaria

March 4, 2021 - 11:23 -- NOT Open Access
Author(s): 
Marin AA, Murillo O, Sussmann RA, Ortolan LS, Battagello DS, de Castro Quirino T, Bittencourt JC, Epiphanio S, Katzin AM, Carvalho LJM
Reference: 
Antimicrob Agents Chemother. 2021 Mar 1:AAC.00004-21

Cerebral malaria (CM) is a severe immunovasculopathy which presents high mortality rate (15-20%), despite the availability of artemisinin-based therapy. More effective immunomodulatory and/or antiparasitic therapies are urgently needed. Experimental Cerebral Malaria (ECM) in mice is used to elucidate aspects involved in this pathology since manifests many of the neurological features of CM.

Subscribe to RSS - perillyl alcohol